Iron stimulates the rate of reduction of hexavalent chromium by human microsomes

Carcinogenesis

Volumn 19, Issue 6, 1998, Pages 1029-1038

  Myers, Charles R ^a   Myers, Judith M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHROMIUM; CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; FLAVOPROTEIN; IRON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CARCINOGENICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME; LUNG; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL; REDUCTION; TOXICITY;

ADULT; CARCINOGENS, ENVIRONMENTAL; CHROMIUM; FEMALE; HUMANS; IRON; LIVER; LUNG; MALE; MICROSOMES; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 0031903570     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.6.1029     Document Type: Article

References (86)

1. Becker,N., Chang-Claude,J. and Frentzel-Beyme,R. (1991) Risk of cancer for arc welders in the Federal Republic of Germany: results of a second follow up (1983-8). Br. J. Ind. Med., 48, 675-683.
2. Langaard,S. and Norseth,T. (1986) Chromium. In Friberg,L., Nordberg,G.F. and Vouk,V.B. (eds) Handbook on the Toxicology of Metals. Elsevier, Amsterdam, pp. 185-210.
3. Leonard,A. and Lauwerys,R.R. (1980) Carcinogenicity and mutagenicity of chromium. Mutat. Res., 76, 227-239.
4. Tandon,S.K. (1982) Organ toxicity of chromium. In Langaard,S. (ed.) Biological and Environmental Aspects of Chromium. Elsevier Biomedical Press, Amsterdam, pp. 209-220.
5. Deschamps,F., Moulin,J.J., Wild,P., Labriffe,H. and Haguenoer,J.M. (1995) Mortality study among workers producing chromate pigments in France. Int. Arch. Occup. Environ. Health, 67, 147-152.
6. Kim,E. and Na, K.J. (1991) Nephrotoxicity of sodium dichromate depending on the route of administration. Arch. Toxicol., 65, 537-541.
7. Bauthio,F. (1992) Toxic effects of chromium and its compounds. Biol. Trace Element Res., 32, 145-153.
8. Graham,J.A., Miller,F.J., Daniels,M.J., Payne,E.A. and Gardner,D.E. (1978) Influence of cadmium, nickel and chromium on primary immunity in mice. Environ. Res., 16, 77-87.
9. Stern,R.M. (1983) Assessment of risk of lung cancer for welders. Arch. Environ. Health, 38, 148-155.
10. Ishikawa,Y., Nakagawa,K., Satoh,Y., Kitagawa,T. Sugano,H., Hirano,T. and Tsuchiya,E. (1994) Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer, 70, 160-166.
11. Tandon,S.K., Saxena,D.K., Gaur,J.S. and Chandra,S.V. (1978) Comparative toxicity of trivalent and hexuvulent chromium. Environ. Res., 15, 90-99.
12. Kirschbaum,B.B., Sprinkel,F.M. and Oken,D.E. (1981) Proximal tubule brush border alterations during the course of chromate nephropathy. Toxicol. Appl. Pharmacol., 58, 19-30.
13. Ishikawa,Y., Nakaguwa,K., Satoh,Y., Kitagawa,T., Sugano,H., Hirano,T. and Tsuchiya,E. (1994) 'Hot spots' of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res., 54, 2343-2346.
14. Taioli,E., Zhitkovich,A., Kinney,P., Udasin,I., Toniolo,P. and Costa,M. (1995) Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol. Trace Elem. Res., 50, 175-180.
15. Costa,M., Zhitkovich,A., Toniolo,P., Taioli,E., Popov,T. and Lukanova,A. (1996) Monitoring human lymphocytic DNA-protein cross-links as biomarkers of biologically active doses of chromate. Environ. Health Perspect., 104, 917-919.
16. Kortenkamp,A., Beyersmann,D. and O'Brien,P. (1987) Uptake of chromium(III) complexes by erythrocytes. Toxicol. Environ. Chem., 14, 23-32.
17. Gray,S.J. and Sterling,K. (1950) The tagging of red cells and plasma proteins with radioactive chromium. J. Clin. Invest., 29, 1604-1613.
18. Buttner,B. and Beyersmann,D. (1985) Modification of the erythrocyte anion carrier by chromate. Xenobiotica, 15, 735-741.
19. Venitl,S. and Levy,L.S. (1974) Mutagenicity of chromates in bacteria and its relevance to chromate carcinogenesis. Nature, 250, 493-495.
20. Cantoni,O. and Costa,M. (1984) Analysis of the induction of alkali sensitive sites in the DNA by chromate and other agents that induce single strand breaks. Carcinogenesis, 5, 1207-1209.
21. Christie,N.T., Cantoni,O., Evans,R.M., Meyn,R.E. and Costa,M. (1984) Use of mammalian DNA repair-deficient mutants to assess the effects of toxic metal compounds on DNA. Biochem. Pharmacol., 33, 1661-1670.
22. Levy,L.S. and Venitt,S. (1986) Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis, 7, 831-835.
23. Tsapakos,M.J., Hampton,T.H. and Wetterhahn,K.E. (1983) Chromium(VI)-induced DNA lesions and chromium distribution on rat kidney, liver and lung. Cancer Res., 43, 5662-5667.
24. Gao,M., Binks,S.P., Chipman,J.K., Levy,L.S., Braithwaite,R.A. and Brown,S.S. (1992) Induction of DNA strand breaks in peripheral lymphocytes by soluble chromium compounds. Human Exp. Toxicol., 11. 77-82.
25. Standeven,A.M. and Wetterhahn,K.E. (1991) Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? Chem. Res. Toxicol., 4, 616-625.
26. Lefebvre,Y. and Pezerat,H. (1992) Production of activated species of oxygen during the chromate(VI)-ascorbate reaction: implication in carcinogenesis. Chem. Res. Toxicol., 5, 461-463.
27. Shi,X. and Dalal,N.S. (1992) The role of Superoxide radical in chromium(VI)-generated hydroxyl radical: the Cr(VI) Haber-Weiss cycle. Arch. Biochem. Biophys., 292, 323-327.
28. Popper,H.H. and Woldrich,A. (1991) Oxygen radical formation a probable mechanism for chromate toxicity. In Graumann,W. and Drukker,J. (eds) Histo- and Cytochemistry as a Tool in Environmental Toxicology. Fischer Verlag, New York, pp. 220-226.
29. Luo,H., Lu,Y., Shi,X., Mao,Y. and Dalal,N.S. (1996) Chromium(IV)-mediated Fenton-like reaction causes DNA damage: implication to genotoxicity of chromate. Ann. Clin. Lab. Sci., 26, 185-191.
30. Molyneux,M.J. and Davies,M.J. (1995) Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species. Carcinogenesis, 16, 875-882.
31. Connett,P.H. and Wetterhahn,K.E. (1983) Metabolism of the carcinogen chromate by cellular constituents. Struct. Bond., 54, 93-124.
32. Standeven,A.M. and Wetterhahn,K.E. (1992) Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis, 13, 1319-1324.
33. Gruber,J.E. and Jennette,K.W. (1978) Metabolism of the carcinogen chromate by rat liver microsomes. Biochem. Biophys. Res. Commun., 82, 700-706.
34. Garcia,J.D. and Wetterhahn-Jennette,K. (1981) Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromate. J. Inorg. Biochem., 14, 281-295.
35. Mikalsen,A., Alexander,J. and Ryberg,D. (1989) Microsomal metabolism of hexavalent chromium. Inhibitory effect of oxygen and involvement of cytochrome P-450. Chem.-Biol. Interactions, 69, 175-192.
36. Mikalsen,A., Alexander,J., Wallin,H., Ingelman-Sundberg,M. and Andersen,R.A. (1991) Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. Carcinogenesis, 12, 825-831.
37. Pratt,P.F. and Myers,C.R. (1993) Enzymatic reduction of chromium(VI) by human hepatic microsomes. Carcinogenesis, 14, 2051-2057.
38. Wrighton,S.A., Vandenbranden,M., Becker,G.W., Black,S.D. and Thomas,P.E. (1992) Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1. Mol. Pharmacol., 41, 76-82.
39. Cashman,J.R., Park,S.B., Yang,Z.-C., Wrighton,S.A., Jacob,P.I. and Benowitz,N.L. (1992) Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. Chem. Res. Toxicol., 5, 639-646.
40. 5. Chem.-Biol. Interactions, 71, 213-221.
41. Sandell,E.B. (1959) Colorimetric Determinations of Traces of Metals. Interscience, New York.
42. Ryberg,D. (1986) Problems with methods for measurement of hexavalent chromium applied to biological samples. Acta Pharmacol. Toxicol., 59(Suppl. VII), 624-626.
43. Hlavica,P. and Kehl,M. (1977) Studies on the mechanism of hepatic microsomal N-oxide formation. The role of cytochrome P-450 and mixed-function amine oxidase in the N-oxidation of NN-dimethylaniline. Biochem. J., 164, 487-496.
44. Stookey,L.L. (1970) Ferrozine - a new spectrophotometric reagent for iron. Anal. Chem., 42, 779-781.
45. Myers,C.R. and Nealson,K.H. (1988) Microbiol reduction of manganese oxides: interactions with iron and sulfur. Geochim. Cosmochim. Acta, 52, 2727-2732.
46. Myers,C.R. and Myers,J.M. (1993) Ferric reductase is associated with the membranes of anaerobically grown Shewanella putrefaciens MR-1. FEMS Microbiol. Lett., 108, 15-22.
47. Carter,P. (1971) Spectrophotometric determination of serum iron at the submicrogram level with a new agent (ferrozine). Anal. Biochem., 40, 450-458.
48. Lowry,O.H., Rosebrough,N.J., Farr,A.L. and Randall,R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
49. Dulley,J.R. and Grieve,P.A. (1975) A simple technique for eliminating interference by detergents in the Lowry method of protein determination. Anal. Biochem., 64, 136-141.
50. Omura,T. and Sato,R. (1964) The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem., 239, 2370-2378.
51. Estabrook,R.W. and Werringloer,J. (1978) The measurement of difference spectra: application to the cytochromes of microsomes. Meth. Enzymol., 52(pt. C), 212-220.
52. Williams,C.H. and Kamin,H. (1962) Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J. Biol. Chem., 237, 587-595.
53. Woods,J.S., Fowler,B.A. and Eaton,D.L. (1984) Studies on the mechanisms of thallium-mediated inhibition of hepatic mixed function oxidase activity. Correlation with inhibition of NADPH-cytochrome c (P-450) reductase. Biochem. Pharmacol., 33, 571-576.
54. Parkinson,A., Ryan,D.E., Thomas,P.E., Jerina,D.M., Sayer,J.M., van Bladeren,P.J., Haniu,M., Shively,J.E. and Levin,W. (1986) Chemical modification and inactivation of rat liver microsomal cytochrome P-450c by 2-bromo-4′-nitroacetophenone. J. Biol. Chem., 261, 11478-11486.
55. Mani,C., Hodgson,E. and Kupfer,D. (1993) Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing mono-oxygenase-mediated N-oxidation. Drug Metab. Dispos., 21, 657-661.
56. Lomri,N., Yang,Z. and Cashman,J.R. (1993) Expression in Escherichia coli of the flavin-containing mono-oxygenase D (form II) from adult human liver: determination of a distinct tertiary amine substrate specificity. Chem. Res. Toxicol., 6, 425-429.
57. Ziegler,D.M. (1988) Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metab. Rev., 19, 1-32.
58. 5 reduction by NADPH-cytochrome P-450 reductase. J. Biol. Chem., 254, 8976-8981.
59. 5 responsible for NADH-supported lipid peroxidation. Biochem. Mol. Biol. Int., 37, 141-150.
60. 3+ chelates and ferritin: enhancement by adriamycin, paraquat, menadione, and anthraquinone 2-sulfonate and inhibition by oxygen. Arch. Biochem. Biophys., 267, 606-613.
61. Morehouse,L.A.,Thomas,C.E. and Aust,S.D. (1984) Superoxide generation by NADPH-cytochrome P-450 reductase: the effect of iron chelators and the role of Superoxide in microsomal lipid peroxidation. Arch. Biochem. Biophys., 232, 366-377.
62. Mikalsen,A., Capellmann,M. and Alexander,J. (1995) The role of iron chelators and oxygen in the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P450 oxidoreductase-dependent chromium(VI) reduction. Analyst, 120, 935-938.
63. Palmer,C.D. and Wittbrodt,P.R. (1991) Processes affecting the remediation of chromium-contaminated sites. Environ. Health Perspect., 92, 25-40.
64. 5, and iron-EDTA reductase activities of liver microsomal NADPH-cytochrome c reductase. Ann. NY Acad. Sci., 212, 428-448.
65. Ziegler,D.M. (1990) Flavin-containing monooxygenases: enzymes adapted for multisubstrate specificity. Trends Pharmacol. Sci., 11, 321-324.
66. Ziegler,D.M. (1993) Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu. Rev. Pharmacol. Toxicol., 33, 179-199.
67. Lomri,N., Gu,Q. and Cashman,J.R. (1992) Molecular cloning of the flavin-containing mono-oxygenase (form II) cDNA from adult human liver. Proc. Natl Acad. Sci. USA, 89, 1685-1689.
68. Cashman,J.R., Park,S.B., Berkman,C.E. and Cashman,L.E. (1995) Role of hepatic flavin-containing mono-oxygenase 3 in drug and chemical metabolism in adult humans. Chem.-Biol. Interactions, 96, 33-46.
69. Holtzman,J.L., Crankshaw,D.L., Peterson,F.J. and Polnaszek,C.F. (1981) The kinetics of the aerobic reduction of nitrofurantoin by NADPH-cytochrome P-450 (c) reductase. Mol. Pharmacol., 20, 669-673.
70. McManus,M.E., Boobis,A.R., Pacifici,G.M., Frempong,R.Y., Brodie,M.J., Kahn,G.C., Whyte,C. and Davies,D.S. (1980) Xenobiotic metabolism in the human lung. Life Sci., 26, 481-487.
71. Hall,P.delaM., Stupans,I., Burgess,W., Birkett,D.J. and McManus,M.E. (1989) Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues. Carcinogenesis, 10, 521-530.
72. 5 gene. Biochem. Biophys. Res. Commun., 209, 894-900.
73. Stohs,S.J. and Bagchi,D. (1995) Oxidative mechanisms in the toxicity of metal ions. Free Rad. Biol. Med., 18, 321-336.
74. Chevion,M., Jiang,Y., Har-El,R., Berenshtein,E., Uretzky,G. and Kitrossky,N. (1993) Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc. Natl Acad. Sci. USA, 90, 1102-1106.
75. 5 in NADH-dependent microsomal reduction of ferric complexes, lipid peroxidation, and hydrogen peroxide generation. Arch. Biochem. Biophys., 324, 282-292.
76. Rothman,R.J., Serroni,A. and Farber,J.L. (1992) Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol. Pharmacol., 42, 703-710.
77. Rogers,J. and Munro,H. (1987) Translation of ferritin light and heavy subunit mRNAs is regulated by intracellular chelatable iron levels in rat hepatoma cells. Proc. Natl Acad. Sci USA, 84, 2277-2281.
78. Ryan,T.P. and Aust,S.D. (1992) The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol., 22, 119-141.
79. Shi,X. and Dalai,N.S. (1990) NADPH-dependent flavoenzymes catalyze one electron reduction of metal ions and molecular oxygen and generate hydroxyl radicals. FEBS Let., 276, 189-191.
80. Shi,X., Dong,Z., Dalal,N.S. and Gannett,P.M. (1994) Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid hydroperoxides. Biochim. Biophys. Acta, 1226, 65-72.
81. Zhitkovich,A., Voitkun,V. and Costa,M. (1996) Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry, 35, 7275-7282.
82. Kortenkamp,A., O'Brien,P. and Beyersmann,D. (1991) The reduction of chromate is a prerequisite of chromium binding to cell nuclei. Carcinogenesis, 12, 1143-1144.
83. Manning,F.C.R., Xu,J. and Patierno,S.R. (1992) Transcription inhibition by carcinogenic chiomate: relationship to DNA damage. Mol. Carcinogenesis, 9, 122-133.
84. Sugden,K.D., Geer,R.D. and Rogers,S.J. (1992) Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry. 31, 11626-11631.
85. Stearns,D.M, Kennedy,L.J., Courtney,K.D., Giangrande,P.H., Phieffer,L.S. and Wetterhahn,K.E. (1995) Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry, 34, 910-919.
86. Shi,X., Sun,X., Gannett,P.M. and Dalal,N.S. (1992) Deferoxamine inhibition of Cr(V)-mediated radical generation and deoxyguanine hydroxylation: ESR and HPLC evidence. Arch. Biochem. Biophys., 293, 281-286.